Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Moncrieff

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal for Immunotherapy of Cancer|August 24, 2022
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissectionZeynep Eroglu, Kristy K Broman, John F Thompson, et al.
Journal of the American College of Surgeons|December 14, 2020
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched AnalysisKristy K Broman, Tasha M Hughes, Lesly A Dossett, et al.
Annals of Surgery|February 7, 2022
International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral CentersKristy K Broman, Tasha M Hughes, Brooke C Bredbeck, et al.
Cancer|April 7, 2021
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2)Kristy Kummerow Broman, Tasha Hughes, Lesly Dossett, et al.
The New England Journal of Medicine|June 8, 2017
Completion Dissection or Observation for Sentinel-Node Metastasis in MelanomaMark B Faries, John F Thompson, Alistair J Cochran, et al.
JAMA Surgery|August 3, 2022
Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial, Jessica S Crystal, John F Thompson, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal for Immunotherapy of Cancer|August 24, 2022
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissectionZeynep Eroglu, Kristy K Broman, John F Thompson, et al.
Journal of the American College of Surgeons|December 14, 2020
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched AnalysisKristy K Broman, Tasha M Hughes, Lesly A Dossett, et al.
Annals of Surgery|February 7, 2022
International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral CentersKristy K Broman, Tasha M Hughes, Brooke C Bredbeck, et al.
Cancer|April 7, 2021
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2)Kristy Kummerow Broman, Tasha Hughes, Lesly Dossett, et al.
The New England Journal of Medicine|June 8, 2017
Completion Dissection or Observation for Sentinel-Node Metastasis in MelanomaMark B Faries, John F Thompson, Alistair J Cochran, et al.
JAMA Surgery|August 3, 2022
Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial, Jessica S Crystal, John F Thompson, et al.
Pageof 4